- Home
- PNW vs MDGL Comparison
PNW vs MDGL Comparison
Compare PNW & MDGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNW
- MDGL
- Stock Information
- Founded
- PNW 1985
- MDGL 2011
- Country
- PNW United States
- MDGL United States
- Employees
- PNW N/A
- MDGL N/A
- Industry
- PNW Electric Utilities: Central
- MDGL Biotechnology: Pharmaceutical Preparations
- Sector
- PNW Utilities
- MDGL Health Care
- Exchange
- PNW Nasdaq
- MDGL Nasdaq
- Market Cap
- PNW 10.3B
- MDGL 9.6B
- IPO Year
- PNW N/A
- MDGL N/A
- Fundamental
- Price
- PNW $89.39
- MDGL $445.36
- Analyst Decision
- PNW Buy
- MDGL Strong Buy
- Analyst Count
- PNW 13
- MDGL 13
- Target Price
- PNW $96.23
- MDGL $514.75
- AVG Volume (30 Days)
- PNW 1.2M
- MDGL 356.3K
- Earning Date
- PNW 11-03-2025
- MDGL 11-04-2025
- Dividend Yield
- PNW 4.07%
- MDGL N/A
- EPS Growth
- PNW N/A
- MDGL N/A
- EPS
- PNW 4.92
- MDGL N/A
- Revenue
- PNW $5,307,180,000.00
- MDGL $740,640,000.00
- Revenue This Year
- PNW $4.47
- MDGL $395.75
- Revenue Next Year
- PNW $4.46
- MDGL $65.73
- P/E Ratio
- PNW $18.17
- MDGL N/A
- Revenue Growth
- PNW 5.70
- MDGL 864.21
- 52 Week Low
- PNW $81.47
- MDGL $265.00
- 52 Week High
- PNW $96.50
- MDGL $469.95
- Technical
- Relative Strength Index (RSI)
- PNW 43.44
- MDGL 57.62
- Support Level
- PNW $87.22
- MDGL $399.00
- Resistance Level
- PNW $93.39
- MDGL $434.98
- Average True Range (ATR)
- PNW 1.48
- MDGL 20.98
- MACD
- PNW -0.50
- MDGL -0.96
- Stochastic Oscillator
- PNW 30.01
- MDGL 67.79
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.